Last reviewed · How we verify
NCT06093139: GIU-PPA-0420
Efficacy of a Mix of Probiotics in Athletes Performance
NA trial testing Probiotic capsule in Healthy in 11 participants. Completed in 5 October 2022.
20 September 2022
Quick facts
| Lead sponsor | Giuliani S.p.A |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 11 |
| Start date | 29 November 2021 |
| Primary completion | 20 September 2022 |
| Estimated completion | 5 October 2022 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Probiotic capsule
- Placebo
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Giuliani S.p.A
Who can join
Adults 18 to 45, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Monocentric Crossover Study to Assess the Tolerability and the Efficacy of a Mix of Probiotic Strains Doses vs Placebo in Athletes Performance This study will intend: \- To assess the tolerability and the efficacy of a food supplements into improving performance in a panel of athletes after repeated use for 4 consecutive weeks, under the normal conditions of use, compared to a placebo.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A Lactobacillus consortium provides insights into the sleep-exercise-microbiome nexus in proof of concept studies of elite athletes and in the general population.
Bongiovanni T, Santiago M, Zielinska K, Scheiman J, et al · · 2025 · cited 8× · PMID 39748236 · DOI 10.1186/s40168-024-01936-4
Verify or expand the search:
- PubMed search for NCT06093139
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Probiotic capsule
Trials testing the same drug.
- NCT06231706 — ZOE BIOME Study: Biotics Influence on Microbiome Ecosystem · NA · completed
- NCT04167475 — Effect of B. Longum 1714™ on Sleep Quality · Phase 2 · completed
- NCT04422327 — The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome · Phase 1, PHASE2 · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06093139 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Giuliani S.p.A
- Last refreshed: 23 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06093139.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing